Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder
- PMID: 20363089
- PMCID: PMC2859987
- DOI: 10.1016/j.jsat.2010.03.006
Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder
Abstract
Compared to the general population, smokers with schizophrenia (SCZ) have reduced success in quitting smoking with usual approaches. This study tested two manualized behavioral counseling approaches-Treatment of Addiction to Nicotine in Schizophrenia (TANS) or Medication Management (MM)-for smokers who were motivated to quit. Individual counseling sessions were provided by mental health clinicians in mental health settings, along with nicotine patch. The two treatments varied in intensity and frequency of sessions. Eighty-seven subjects were randomized and attended at least one treatment session. Twenty-one percent (n = 18) of participants had continuous abstinence at 12 weeks after the target quit date, which was not significantly different between conditions (15.6% TANS vs. 26.2% MM, chi(2) = 1.50, p = .221). Smokers in both groups significantly reduced smoking as measured by cigarettes per day and expired carbon monoxide. Findings support that mental health clinicians can be trained to effectively help smokers with SCZ maintain tobacco abstinence.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Personalized dosing of nicotine replacement therapy versus standard dosing for the treatment of individuals with tobacco dependence: study protocol for a randomized placebo-controlled trial.Trials. 2020 Jun 29;21(1):592. doi: 10.1186/s13063-020-04532-7. Trials. 2020. PMID: 32600406 Free PMC article.
-
Comparing smoking treatment programs for lighter smokers with and without a history of heavier smoking.J Subst Abuse Treat. 2009 Oct;37(3):247-55. doi: 10.1016/j.jsat.2009.01.006. Epub 2009 Mar 31. J Subst Abuse Treat. 2009. PMID: 19339135 Free PMC article. Clinical Trial.
-
Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial.BMC Med. 2016 Jun 7;14:80. doi: 10.1186/s12916-016-0626-2. BMC Med. 2016. PMID: 27233840 Free PMC article. Clinical Trial.
-
Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation.Cochrane Database Syst Rev. 2019 Apr 18;4(4):CD013308. doi: 10.1002/14651858.CD013308. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2023 Jun 19;6:CD013308. doi: 10.1002/14651858.CD013308.pub2. PMID: 30997928 Free PMC article. Updated.
-
A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.Clin Ther. 2008 May;30(5):800-12. doi: 10.1016/j.clinthera.2008.05.010. Clin Ther. 2008. PMID: 18555928 Review.
Cited by
-
A systematic review of digital interventions for smoking cessation in patients with serious mental illness.Psychol Med. 2023 Aug;53(11):4856-4868. doi: 10.1017/S003329172300123X. Epub 2023 May 10. Psychol Med. 2023. PMID: 37161690 Free PMC article.
-
Tobacco smoking, related harm and motivation to quit smoking in people with schizophrenia spectrum disorders.Health Psychol Res. 2020 May 27;8(1):9042. doi: 10.4081/hpr.2020.9042. eCollection 2020 May 27. Health Psychol Res. 2020. PMID: 32510003 Free PMC article.
-
Abstinence and Use of Community-Based Cessation Treatment After a Motivational Intervention Among smokers with Severe Mental Illness.Community Ment Health J. 2016 May;52(4):446-56. doi: 10.1007/s10597-016-9998-1. Epub 2016 Mar 1. Community Ment Health J. 2016. PMID: 26932324 Clinical Trial.
-
Expanding Cessation Pharmacotherapy Via Videoconference Educational Outreach to Prescribers.Nicotine Tob Res. 2015 Aug;17(8):960-7. doi: 10.1093/ntr/ntv006. Nicotine Tob Res. 2015. PMID: 26180220 Free PMC article. Clinical Trial.
-
Improvement in Body Image, Perceived Health, and Health-Related Self-Efficacy Among People With Serious Mental Illness: The STRIDE Study.Psychiatr Serv. 2016 Mar;67(3):296-301. doi: 10.1176/appi.ps.201400535. Epub 2015 Nov 2. Psychiatr Serv. 2016. PMID: 26522674 Free PMC article. Clinical Trial.
References
-
- Addington J, el-Guebaly N, Campbell W, Hodgins DC, Addington D. Smoking cessation treatment for patients with schizophrenia. Am J Psychiatry. 1998;155(7):974–976. - PubMed
-
- Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, Jansons S, Wilhelm K. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. American Journal of Psychiatry. 2006;163(11):1934. - PubMed
-
- Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Archives of General Psychiatry. 1961;4:461–471. - PubMed
-
- Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. British Journal of Psychiatry. 2000;177:212–217. - PubMed
-
- Covey LS, Hughes D, Glassman AH, Blazer D, George LK. Ever-smoking, quitting, and psychiatric disorders: evidence from the Durham, North Carolina, Epidemiologic Catchment Area. Tobacco Control. 1994;3:222–227.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical